Table 4 Current and recommended treatment in patients with confirmed COPD and proportion of patients in whom a treatment was recommended who were receiving that treatment
No. currently receiving the treatment | No. for whom the treatment was recommended | No. receiving the treatment recommended for them | |
|---|---|---|---|
(N = 278) | (N = 278) | (N = 278) | |
SAAC | 124 (44.6%) | 109 (39.2%) | 59/109 (54%) |
LAB2 agonists | 124 (44.6%) | 80 (28.8%) | 37/80 (46%) |
LAAC | 50 (18.0%) | 53 (19.1%) | 12/53 (23%) |
Inhaled steroids | 167 (60.0%) | 48 (17.0%) | 39/48 (81%) |
Mucolytics | 9 (3%) | 144 (53.0%) | 6/144 (4%) |